The Botanical Adulteration Prevention Program has issued a lab guidance document on turmeric. The publication is timely as interest in the botanical, which was already high, has spiked during the current coronavirus crisis.
The Advisory Board on the Quality of Botanical Supplements has created a consensus paper to clarify how experts can examine the quality, safety and efficacy of turmeric supplements.
Sports nutrition products continue to be a source of concern for regulators, but there are signs the situation is improving. And statistics back the notion that supplements are not the huge risk factor for athletes that they’re sometimes made out to...
Natural astaxanthin from algae has been “undisputedly demonstrated” to be the most effective form of the ingredient for a variety of health benefits, according to a new review.
The year is new and a lot of people are getting out their crystal balls. NutraIngredients-USA is no exception, and here are our top big issues that will impact the dietary supplements industry in this new decade.
The Botanical Adulterants Prevention Program has released a bulletin on olive oil adulteration that shows that the issue, though widely acknowledged, continues to plague the market.
By Karen Howard, CEO and Executive Director of Organic & Natural Health Association
Successful evaluation of the progress or travails of 2019 requires more than measuring growth in dietary supplements sales, which by that measure alone indicates we had a banner year.
By Stefan Gafner and Mark Blumenthal, American Botanical Council
The news about CBD and hemp extracts dominated 2019, says the American Botanical Council. But issues surrounding the ongoing climate crisis, questions of sustainability, and the ongoing questions of adulteration were important topics as well.
By Steve Mister, President & CEO, Council for Responsible Nutrition
The question of CBDs, and of a mandatory product listing, have dominated a year that for the dietary supplement industry has not been as tumultuous as some.
A call from FDA to consumers to avoid products recalled as part of an enforcement action underscores how difficult it can be to get offending articles off the market.
An interim federal government funding measure does not include language creating a legal pathway for hemp/CBD products, despite advocacy on the part of stakeholders including lawmakers and trade organizations.
The growing obesity epidemic has flummoxed public health officials. Unfortunately, the dietary supplement industry has a checkered history in helping to find solutions.
FDA needs new tools to effectively deal with an expanding supplement marketplace, according to agency official Lowell Schiller. This is especially true when contemplating the flood of CBD products, with many more yet to come.
Athletes using cannabidiol (CBD) products should be prepared for a very real risk they could fail anti-doping tests due to contamination of banned tetrahydrocannabinol (THC), ESSNA has warned.
The Botanical Adulterants Prevention Program is nearing the final stage of its initiative to offer industry a way to keep adulterated materials from turning up in finished goods on the shelf.
